Saturday, April 22, 2017 5:05:48 PM
If you have been a shareholder here you can not really see any benefit to this stock. RS, 4 offerings, dilution, share count tripling in last 7 years. Add to that nothing but 5 failed drug tests in 7 years with 5 new drugs. If you invested $100 7 years ago, management has absorbed all but a dime.
In all fairness can you share one benefit a long shareholder has experienced?
Even management could not plan a successful merger. Thus far along with every "botched" test they could not achieve one simple goal .... merger. The 90% voting are not voting for merger, RS, or name change. They are voting to get rid of management in a worthless CEO Cully ....period.
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM